TGA Approval

ILARIS canakinumab (rmc) 150mg/1mL solution for injection in vials (279239)

ARTG ID

279239

ARTG Name

ILARIS canakinumab (rmc) 150mg/1mL solution for injection in vials

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

May 26, 2017

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/f08b9faeb3d766857380219953d96149.pdf

https://medical-cdn.nocode.com/drug_tga/cc747173b4e83f86c61369457b5d1ce2.pdf

Ingredient Name

Canakinumab

Empowering clinical research with data-driven insights and AI-powered tools.

ILARIS canakinumab (rmc) 150mg/1mL solution for injection in vials (279239) - TGA 批准文号 | MedPath